Contact Info

Peter Merian-Weg 12

Phone: +41 61 965 11 11


Straumann Connections 3/16: “Lifetime Plus Guarantee” for Straumann® Roxolid® implants


Roxolid® has brought a new level of confidence to implant dentistry that enables Straumann to offer an industry leading guarantee. In this issue of “Straumann Connections”, Frank Hemm, Executive Vice President and Head of Customer Solutions & Education at Straumann, explains why Straumann has taken this decision and what it means for surgeons and patients.


Roxolid® – the dental implant material for superior strength and more indications

Roxolid® from Straumann (introduced 2009) has been specifically designed for use in dental implantology. It is a unique implant material – a metal alloy composed of ~15 % zirconium and ~ 85 % titanium – combining excellent osseointegrative properties with high mechanical strength. Roxolid® leads to increased mechanical resistance [R1] and up to 21 % higher fatigue strength compared to titanium implants [R2]. This allows dental professionals to use reduced diameter implants to preserve bone and reduce the number of invasive grafting procedures [R3]. In combination with Straumann’s unique SLActive® surface, Roxolid® implants offer increased predictability even in challenging protocols [R4-10], broader treatment possibilities even for patients with compromised health [R11-17] as well as safer and reduced treatment times (from 6 – 8 weeks down to 3 – 4 weeks) in all indications [R18].

R1 Kobayashi E, Matsumoto S, Doi H, Yoneyama T, Hamanaka H. Mechanical properties of the binary titanium-zirconium alloys and their potential for biomedical materials. J Biomed Mater Res. 1995 Aug;29(8):943-50. R2 Bernhard N, Berner S, de Wild M, Wieland M: The binary TiZr Alloy – a newly developed Ti alloy for use in dental implants, Forum Implantol., 2009, 5, 30 -39. R3 Data on file R4 Benic G.I., Gallucci G.O., Mokti M., Hämmerle C.H., Weber H.P., Jung R.E., Titanium-zirconium narrow-diameter versus titanium regular diameter implants for anterior and premolar single crowns: one-year results of a randomized controlled clinical study. Journal of Clinical Periodontology 2013; [Epub ahead of print] R5Schwarz F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA® titanium implants: a pilot study in dogs. J Clin. Periodontol. 34.1 (2007): 78–86 12 Lai H.C., Zhuang L.F., Zhang Z.Y., Wieland M., Liu X., Bone apposition around two different sandblasted, large-grit and acid-etched implant surfaces at sites with coronal circumferential defects: An experimental study in dogs. Clin. Oral Impl. Res. 2009; 20(3): 247–53. R6 Buser D., Wittneben J., Bornstein M.M., Grütter L., Chappuis V., Belser U.C., Stability of contour augmentation and esthetic outcomes of implant-supported single crowns in the esthetic zone: 3-year result of a prospective study with early implant placement post extraction. J. Periodontol. 2011 March; 82(3): 342–9. 7 Buser D., Chappuis V., Kuchler U., Bornstein M.M., Wittneben J.G., Buser R., Cavusoglu Y., Belser U.C., Long-term stability of early implant placement with contour augmentation. J. Dent Res. 2013 Dec; 92 (12 Suppl.): 176S-82S. R8 Nicolau P., Reis R., Guerra F., Rocha S., Tondela J., Brägger U., Immediate and early loading of Straumann® SLActive implants: A Five-Year Follow-up. Presented at the 19th Annual Scientific Meeting of the European Association of Osseointegration – 9 October 2010, Glasgow 10 International Diabetes Federation.   R11 6 Bo Wen et al. The osseointegration behavior of titanium-zirconium implants in ovariectomized rabbits. Clin Oral Implants Res. 2013 Feb 21. R12 Schlegel K.A., Prechtl C., Möst T., Seidl C., Lutz R., von Wilmowsky C., Osseointegration of SLActive® implants in diabetic pigs Clin. Oral Implants Res. 2013 Feb; 24 (2): 128–34. 13 Reginster J.Y., Burlet N., Osteoporosis: a still increasing prevalence. Bone. 2006 Feb; 38 (2 Suppl. 1): S4-9. R14 Mardas N., Schwarz F., Petrie A., Hakimi A.R., Donos N., The effect of SLActive® surface in guided bone formation in osteoporotic-like conditions Clin. Oral Implants Res. 2011 Apr; 22 (4): 406 15. 15 WHO: R16 iData Report, Dental Implants and Final Abutments, Europe 2012 17iData Report, Dental Implants and Final Abutments, USA 2012 R18 Rupp F., Scheideler L., Olshanska N., de Wild M., Wieland M., Geis-Gerstorfer J., Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. Journal of Biomedical Materials Research A, 76(2): 323–334, 2006. R19 De Wild M., Superhydrophilic SLActive® implants. Straumann document 151.52, 2005 20 Katharina Maniura, Laboratory for Materials – Biology Interactions Empa, St. Gallen, Switzerland, Protein and blood adsorption on Ti and TiZr implants as a model for osseointegration, EAO 22nd Annual Scientific Meeting, October 17–19 2013, Dublin R21 Schwarz F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA® titanium implants: an immunohistochemical study in dogs. J. Clin. Periodontol. 35.1 (2008): 64–75.R22 Rausch-fan X., Qu Z., Wieland M., Matejka M., Schedle A., Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces, Dental Materials 2008 Jan.; 24(1): 102-10. Epub 2007 Apr. 27. R23 Schwarz F., Herten M., Sager M., Wieland M., Dard M., Becker J., Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA®titanium implants: Preliminary results of a pilot study in dogs. Clinical Oral Implants Research, 11(4): 481–488, 2007. 24Lang, N.P., et al., Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans, Clin. Oral Implants. Res 22.4 (2011): 349–56. R25 Raghavendra S., Wood M.C., Taylor T.D.. Int. J. Oral Maxillofac. Implants. 2005 May–Jun; 20(3): 425–31. R26 Oates T.W., Valderrama P., Bischof M., Nedir R., Jones A., Simpson J., Toutenburg H., Cochran D.L., Enhanced implant stability with a chemically modified SLA® surface: a randomized pilot study. Int. J. Oral Maxillofac. Implants. 2007; 22(5): 755–760.
By | 2017-08-17T08:29:45+00:00 June 13th, 2016|Dental Implants, News|0 Comments

Leave A Comment